-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Axsome Therapeutics, Raises Price Target to $169

Benzinga·12/31/2025 13:51:15
Listen to the news
Needham analyst Ami Fadia maintains Axsome Therapeutics (NASDAQ:AXSM) with a Buy and raises the price target from $154 to $169.